The benefit of adjuvant chemotherapy in pathological T1-3N0M0 rectal mucinous adenocarcinoma: no improvement survival outcomes based on long-term survival analysis of large population data.
Hualin LiaoTengyu ZengXianqiang XieJiyang LiDongsheng LiKejin YanFan ChenHongliang ZhuPublished in: Journal of gastrointestinal oncology (2024)
Our study found that RM is a poor prognostic factor in pathological T1-3N0M0 RC. However, AT does not appear necessary to improve survival outcomes of pathological T1-3N0M0 RM.